ATE193443T1 - Verwendung eines imidazols zur herstellung eines medikamentes zur behandlung der arteriosklerose - Google Patents

Verwendung eines imidazols zur herstellung eines medikamentes zur behandlung der arteriosklerose

Info

Publication number
ATE193443T1
ATE193443T1 AT94909690T AT94909690T ATE193443T1 AT E193443 T1 ATE193443 T1 AT E193443T1 AT 94909690 T AT94909690 T AT 94909690T AT 94909690 T AT94909690 T AT 94909690T AT E193443 T1 ATE193443 T1 AT E193443T1
Authority
AT
Austria
Prior art keywords
arteriosclerosis
medication
imidazole
treatment
production
Prior art date
Application number
AT94909690T
Other languages
English (en)
Inventor
Jose Halperin
Carlo Brugnara
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Application granted granted Critical
Publication of ATE193443T1 publication Critical patent/ATE193443T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
AT94909690T 1993-02-18 1994-02-18 Verwendung eines imidazols zur herstellung eines medikamentes zur behandlung der arteriosklerose ATE193443T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/018,835 US5358959A (en) 1993-02-18 1993-02-18 Methods for treating arteriosclerosis
PCT/US1994/001749 WO1994018968A1 (en) 1993-02-18 1994-02-18 Methods for treating arteriosclerosis

Publications (1)

Publication Number Publication Date
ATE193443T1 true ATE193443T1 (de) 2000-06-15

Family

ID=21790012

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94909690T ATE193443T1 (de) 1993-02-18 1994-02-18 Verwendung eines imidazols zur herstellung eines medikamentes zur behandlung der arteriosklerose

Country Status (8)

Country Link
US (1) US5358959A (de)
EP (1) EP0646005B1 (de)
JP (1) JPH08503958A (de)
AT (1) ATE193443T1 (de)
AU (1) AU6243894A (de)
CA (1) CA2118314A1 (de)
DE (1) DE69424732D1 (de)
WO (1) WO1994018968A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6395494B1 (en) 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
US5512591A (en) * 1993-02-18 1996-04-30 President And Fellows Of Harvard College Treatments for diseases characterized by neovascularization
US5633274A (en) * 1993-02-18 1997-05-27 President And Fellows Of Harvard College Cancer treatments
GB2293323A (en) * 1994-09-12 1996-03-27 Orion Yhtymae Oy Antibiotics and bismuth salts for treating bacterial infections
WO1996008240A1 (en) * 1994-09-16 1996-03-21 President And Fellows Of Harvard College Use of aromatic halides for treating mammalian cell proliferation
US6028103A (en) * 1994-09-16 2000-02-22 Children's Medical Center Corporation Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation
DE19503160A1 (de) * 1995-02-01 1996-08-08 Bayer Ag Verwendung von Phenylcyclohexylcarbonsäureamiden
HRP960015B1 (en) * 1995-02-01 2000-12-31 Bayer Ag Substituted indole derivatives
US5556871A (en) * 1995-04-24 1996-09-17 President & Fellows Of Harvard College Method for treating epithelial precancerous lesions with topical inidazoles
US5645839A (en) * 1995-06-07 1997-07-08 Trustees Of Boston University Combined use of angiotensin inhibitors and nitric oxide stimulators to treat fibrosis
US7611533B2 (en) 1995-06-07 2009-11-03 Cook Incorporated Coated implantable medical device
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US5993787A (en) * 1996-09-13 1999-11-30 Johnson & Johnson Consumer Products, Inc. Composition base for topical therapeutic and cosmetic preparations
US5981471A (en) * 1997-02-06 1999-11-09 Entremed, Inc. Compositions and methods for inhibiting cellular proliferation
US20060025329A1 (en) * 1997-02-06 2006-02-02 Todd Hembrough Compositions and methods for inhibiting cellular proliferation comprising TFPI fragments
US6946439B2 (en) 1997-02-06 2005-09-20 Entre Med, Inc. Compositions and methods for inhibiting cellular proliferation comprising TFPI fragments
US6309339B1 (en) 1997-03-28 2001-10-30 Endosonics Corporation Intravascular radiation delivery device
US6033357A (en) * 1997-03-28 2000-03-07 Navius Corporation Intravascular radiation delivery device
US6800658B2 (en) * 1997-11-20 2004-10-05 Children's Medical Center Corporation Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferation
CN1119334C (zh) 1997-11-20 2003-08-27 哈佛学院校长及员工 用于治疗或预防以异常细胞增殖为特征之疾病的经取代的11－苯基－二苯并吖庚因化合物
US6992079B2 (en) * 1997-11-20 2006-01-31 President Fellows of Harvard College Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
WO2000024402A1 (fr) * 1998-10-27 2000-05-04 Roumen Antonov Utilisation d'antifongiques dans le traitement des scleroses
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
CZ20033145A3 (cs) * 2001-05-23 2004-10-13 Antonovároumen Identifikace parazitických plísní v organismu a jejich léčení
FR2825024B1 (fr) * 2001-05-23 2005-06-24 Roumen Antonov Identification de champignons parasites de l'organisme, et leur traitement
AU2003259028A1 (en) * 2002-06-10 2003-12-22 Combinatorx, Incorporated Combinations for the treatment of rheumatoid arthritis
KR100478671B1 (ko) * 2002-07-15 2005-03-22 사회복지법인 삼성생명공익재단 클로트리마졸을 포함하는 혈관 재협착 예방 및 치료용약학 조성물, 및 스텐트
CA2503962A1 (en) * 2002-10-30 2004-05-13 Ralf Koehler Compounds, methods and devices for inhibiting neoproliferative changes in blood vessel walls
US9072728B2 (en) * 2003-09-18 2015-07-07 Children's Medical Center Corporation Treatment of severe distal colitis
AU2006210641A1 (en) * 2005-02-01 2006-08-10 Icagen, Inc. Imines as ion channel modulators
WO2007033307A2 (en) * 2005-09-13 2007-03-22 The Regents Of The University Of California Inhibition of intermediate-conductance calcium activated potassium channels in the treatment and/or prevention of atherosclerosis
US20080090760A2 (en) * 2005-12-09 2008-04-17 Todd Hembrough Compositions and Methods for Inhibiting Cellular Proliferation
FR3070857B1 (fr) * 2017-09-11 2019-09-06 Centre Scientifique De Monaco Utilisation de la scleritine en tant qu'agent protecteur de cellules contre des agents toxiques

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4916118A (en) * 1986-08-18 1990-04-10 Board Of Regents, The University Of Texas System Pharmaceutical administration systems containing chemotactic peptides
US5132315A (en) * 1989-05-19 1992-07-21 The United States Of America As Represented By The Department Of Health And Human Services Therapeutic application of an anti-invasive compound
EP0525123B1 (de) * 1990-06-20 1997-09-17 PHARMACIA & UPJOHN COMPANY Antiatherosklerotische und antithrombotische 1-benzopyran-4-on- und 2-amino-1,3-benzoxazin-4-on-derivate

Also Published As

Publication number Publication date
CA2118314A1 (en) 1994-09-01
EP0646005A4 (de) 1996-03-27
EP0646005B1 (de) 2000-05-31
WO1994018968A1 (en) 1994-09-01
EP0646005A1 (de) 1995-04-05
DE69424732D1 (de) 2000-07-06
AU6243894A (en) 1994-09-14
JPH08503958A (ja) 1996-04-30
US5358959A (en) 1994-10-25

Similar Documents

Publication Publication Date Title
DE69424732D1 (de) Verwendung eines imidazols zur herstellung eines medikamentes zur behandlung der arteriosklerose
DE69435137D1 (de) Prävention und behandlung von pathologien, die mit einer abnormalen proliferationglatter muskelzellen verbunden sind
DK0706521T3 (da) Imider som TNF-alfa-inhibitorer
ATE218164T1 (de) Hemmung der fortpflanzung von arterienglattmuskelzellen
YU45843B (sh) Postupak za dobijanje nosećeg katalizatora za polimerizaciju etilena
DE69528475D1 (de) Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie
MY129973A (en) Sulphonylbenzyl-substituted pyridones.
ATE13187T1 (de) Verfahren zur behandlung von linearem polyaethylen niedriger dichte mit freie radikale bildenden organischen peroxiden.
ES2155531T3 (es) Compuestos de poliaminas para el tratamiento de desordenes vasculares proliferativos.
DE69232911D1 (de) Verwendung eines polyhydroxybenzamids oder dessen Derivat zur Herstellung eines Medikaments für die Behandlung von viralen Infektionen
ATE272404T1 (de) Verwendung von taurolidine zur herstellung eines arzneimittels zur behandlung von leukämien
DK1479394T3 (da) Anvendelse af epidermal vækstfaktor (EGF) til ögning af vækstforögelse hos et dyr
ATE63815T1 (de) Verwendung von zinn-protoporphyrin und zinnmesoporphyrin zur herstellung eines arzneimittels fuer die behandlung von psoriasis.
PT87683A (pt) Anti-inflammatory furanones
DE69506686D1 (de) Verwendung von bis (amidinobenzidazolen) zur herstellung eines medikamentes für die hemmung der retroviral integrase
DE69333413D1 (de) 5-ht2-antagonisten in der behandlung venöser zustände
DE69423577D1 (de) Verwendung von Oenothein B zur Herstellung eines Medikaments zur Behandlung der durch Hyperandrogenität bedingte Störungen.
ATE212845T1 (de) Verwendung von cytochrome - p 450 - inhibitoren zur hemmung des stoffwechsels von stickstoffsubstituierten acridinen
IL91572A0 (en) Pharmaceutical compositions for treating conditions appearing after damage comprising ace inhibitors
DE59202618D1 (de) BIOTENSIDE ESTER MIT VITAMIN-D-VERBINDUNGEN; IHRE HERSTELLUNG UND AUFARBEITUNG ZU SPONTAN DISPERGIERBAREN kONZENTRATEN, SOWIE IHRE VERWENDUNG ZUR BEHANDLUNG VON TUMOREN.
HU9201799D0 (en) New 2-amino-5-ciano-1,4-dihydropiridine-derivatives, process for their use and their use as medicaments
ATE234613T1 (de) Verwendung von comt inhibitoren zur herstellung eines arzneimittels zur vorbeugung von diabetischen vaskulären funktionsstörungen
DE69818809D1 (de) Verfahren zur behandlung von narbengewebe
ES2101100T3 (es) Un producto para el tratamiento del cancer de higado y su procedimiento de manufactura.
EP0929306A4 (de) Verfahren zur hemmung der vermehrung der glatten muskelzellen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties